ADMA Biologics Inc
NASDAQ:ADMA
ADMA Biologics Inc
Inventory
ADMA Biologics Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADMA Biologics Inc
NASDAQ:ADMA
|
Inventory
$177.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
57%
|
CAGR 10-Years
68%
|
|
Abbvie Inc
NYSE:ABBV
|
Inventory
$4.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Inventory
$1.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-1%
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$8.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
24%
|
CAGR 10-Years
11%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Inventory
$813.1m
|
CAGR 3-Years
40%
|
CAGR 5-Years
43%
|
CAGR 10-Years
54%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Inventory
$2.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
41%
|
See Also
What is ADMA Biologics Inc's Inventory?
Inventory
177.7m
USD
Based on the financial report for Mar 31, 2024, ADMA Biologics Inc's Inventory amounts to 177.7m USD.
What is ADMA Biologics Inc's Inventory growth rate?
Inventory CAGR 10Y
68%
Over the last year, the Inventory growth was 8%. The average annual Inventory growth rates for ADMA Biologics Inc have been 24% over the past three years , 57% over the past five years , and 68% over the past ten years .